Source: ClinicaSpace

Wave Form Systems: WaveForm Technologies Announces Clinical Trial Results For Its Continuous Glucose Monitoring System

WaveForm Technologies announced it had completed four human clinical trials for its proprietary continuous glucose monitoring ("CGM") system.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Charles Watkins's photo - President & CEO of Wave Form Systems

President & CEO

Charles Watkins

CEO Approval Rating

70/100

Read more